C
Charles Rosenblum
Researcher at Merck & Co.
Publications - 63
Citations - 4946
Charles Rosenblum is an academic researcher from Merck & Co.. The author has contributed to research in topics: Leptin & Leptin receptor. The author has an hindex of 24, co-authored 63 publications receiving 4771 citations. Previous affiliations of Charles Rosenblum include Pennington Biomedical Research Center.
Papers
More filters
Patent
Combination therapy for treating alzheimer's disease
TL;DR: In this article, a drug combination comprised of an HMG-CoA reductase inhibitor in combination with a COX-2 inhibitor was proposed for treating or preventing Alzheimer's disease.
Journal ArticleDOI
The conductance of solutions of sodium benzylpenicillinate.
D. T. Woodbury,Charles Rosenblum +1 more
TL;DR: It seems inadmissible, despite the experiments cited, that a sodium salt of Penicillin should have a negligible conductance, although it is altogether reasonable to expect the penicillin anion to have a lower mobility than most inorganic or small organic anions.
Journal ArticleDOI
Disposition of ronidazole by swine. 1. Radiocarbon content of tissues.
Frank J. Wolf,Francis P. Baylis,Gary E. Smith,Charles Rosenblum,Henry T. Meriwether,Raul E. Alvaro,Donald E. Wolf,Frank R. Koniuszy,Theodore A. Jacob +8 more
Journal ArticleDOI
Applications of the urinary tracer test (of Schilling) as an index of vitamin B12 absorption.
Journal ArticleDOI
The determination of the stability of vitamin B12 in multivitamin mixture by a radioactive indicator method.
Charles Rosenblum,D. T. Woodbury +1 more
TL;DR: By means of cobalt 60 labeled vitamin as radioactive tracer, the stability of vitamin B12, after thirteen months' storage in four different multivitamin combinations, has been determined.